Oral Oncology
Volume 40, Issue 8 , Pages 780-786, September 2004

Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth

  • Tânia Mara Pimenta Amaral

      Affiliations

    • Department of Semiology and Pathology, School of Dentistry, Federal University of Minas Gerais, Rua Juiz de Fora, 1090/102, 30180-061 Belo Horizonte, Brazil
  • ,
  • Addah Regina da Silva Freire

      Affiliations

    • Department of Radiology, School of Dentistry, Federal University of Minas Gerais, Av: Arthur Bernades, 60/1501, 30350-310 Belo Horizonte, Brazil
  • ,
  • André Lopes Carvalho

      Affiliations

    • Department of Head and Neck Surgery and Otorhinolaryngology, Centro de Tratamento e Pesquisa Hospital do Cancer A.C. Camargo, Rua Prof. Antônio Prudente, 211, 01509-900 São Paulo, Brazil
  • ,
  • Clóvis Antônio Lopes Pinto

      Affiliations

    • Department of Pathology, Centro de Tratamento e Pesquisa Hospital do Cancer A.C. Camargo, Rua Prof. Antônio Prudente, 211, 01509-900 São Paulo, Brazil
  • ,
  • Luiz Paulo Kowalski

      Affiliations

    • Department of Head and Neck Surgery and Otorhinolaryngology, Centro de Tratamento e Pesquisa Hospital do Cancer A.C. Camargo, Rua Prof. Antônio Prudente, 211, 01509-900 São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55-11-3341-0325; fax: +55-11-3277-6789

Received 9 September 2003; accepted 14 October 2003.

Abstract 

The incidence of occult neck metastasis in early stage tumours of the tongue and floor of the mouth varies from 20% to 30%, and the survival rates in 5 years from 73% to 97%. This study analyzes the rates of occult metastasis and prognostic factors for clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. The records of patients with squamous cell carcinoma of the tongue and floor of the mouth, without prior treatment and treated by surgery between 1965 and 1998 were reviewed. All cases were re-staged and the surgical specimens were reviewed. This study included 193 patients, 145 men (75.1%), with ages ranging from 29 to 89 years old (mean, 60 years). The tumour site was the tongue in 132 cases (68.4%), the floor of the mouth in 45 (23.3%) and both in 16 (8.3%). With regard to stage, 85 cases were at clinical stage I (44.0%) and 108, clinical stage II (56.0%). One hundred and seventeen patients (60.6%) were submitted to a neck dissection and 27 (23.1%) had metastasic lymph nodes (pN+). The only factor associated with the presence of occult metastasis for all patients was the presence of muscular infiltration (p=0.020); for tongue tumours the presence of vascular embolization (p=0.043) and the presence of desmoplastic reaction (p=0.050); for floor of the mouth tumours and T2 tumors, the histological grade (p=0.025 and p=0.035, respectively). Disease-free survival in 5 years was 66.4% and overall survival in 5 years 68.5%. The only factor associated with disease-free survival was the presence of muscular infiltration (p=0.019) and with overall survival were gender (p=0.002) and clinical stage (p=0.031). Tumours of the tongue and floor of the mouth in the initial stages, which had muscular infiltration showed a higher probability of occult metastasis and lower disease-free survival; T2 tumours showed a worse survival as did patients of the male gender.

Keywords:  Lymph node metastasis, Prognosis, Squamous cell carcinoma, Oral tongue, Floor of the mouth, Oral cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(03)00226-4

doi:10.1016/j.oraloncology.2003.10.009

Oral Oncology
Volume 40, Issue 8 , Pages 780-786, September 2004